US2019201383A1PendingUtilityA1

Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts

58
Assignee: VASCULAR THERAPIES INCPriority: Jan 16, 2001Filed: Mar 8, 2019Published: Jul 4, 2019
Est. expiryJan 16, 2021(expired)· nominal 20-yr term from priority
A61M 2202/0478A61P 7/02A61L 2300/204A61K 9/0024A61K 31/573A61M 2039/0258A61M 1/3655A61L 31/16A61K 31/122A61L 2300/252A61K 31/727A61K 31/436A61P 37/06A61P 43/00A61L 2300/416A61P 41/00A61L 27/54A61K 31/337A61L 27/225A61P 9/00A61P 31/00A61P 9/10A61M 1/16A61M 2039/0261A61L 27/20A61L 27/44A61M 39/0247A61P 7/08A61M 2202/0468A61K 31/395
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention is a prosthetic device generally placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material. Methods of perivascular antiproliferative drug administration also are disclosed.

Claims

exact text as granted — not AI-modified
1 . A method of preventing or treating vasculoproliferative disease in vascular structures, which comprises the step of:
 administering extravascularly and locally an antiproliferative effective amount of an antiproliferative agent to the vascular structure.   
     
     
         2 . A method according to  claim 1  wherein the agent comprises rapamycin. 
     
     
         3 . A method according to  claim 1  wherein the antiproliferative agent is administered perivascularly. 
     
     
         4 . A method according to  claim 1  wherein extravascular, local administration is accomplished by means of an implantable, antiproliferative agent eluting, perivascular vascular sleeve, the sleeve comprising a matrix material imbibed with the agent. 
     
     
         5 . A method according to  claim 4  wherein the sleeve is substantially circumvascular. 
     
     
         6 . A method according to  claim 4  wherein the matrix material comprises fibrin. 
     
     
         7 . A method according to  claim 4  wherein the agent comprises rapamycin and heparin 
     
     
         8 . A method according to  claim 4  wherein the matrix material comprises collagen. 
     
     
         9 . A method according to  claim 4  wherein the matrix material comprises chitosan. 
     
     
         10 . An implantable, antiproliferative agent-administering perivascular sleeve adapted to be placed in contact with the exterior of a vascular structure comprising:
 a) A flexible, bioabsorbing, agent-eluting matrix material, the material having a vascular-sized lumen passing substantially through said matrix material, the matrix material having dispersed therein:   b) an antiproliferative agent.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.